Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gardasil Efficacy In Adolescent Females Supported By Advisory Committee

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA’s Vaccines & Related Biological Products Advisory Committee unanimously agrees Merck’s human papillomavirus vaccine is safe and effective for use in females ages nine to 26 years.

You may also be interested in...



Merck’s Gardasil HPV Vaccine Clears FDA

The vaccine, which is administered in a three-dose series, is available for ordering at $120 per dose, Merck says.

Merck’s Gardasil HPV Vaccine Clears FDA

The vaccine, which is administered in a three-dose series, is available for ordering at $120 per dose, Merck says.

Gardasil Efficacy In Patients Already Infected With HPV Will Be Addressed By Advisory Panel

Potential of strains not contained in Merck’s HPV vaccine to offset efficacy of Gardasil will also be discussed at the committee’s May 18 meeting.

Topics

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel